Philips emphasizes AI, workflow at RSNA 2022
December 1, 2022 -- CHICAGO - With an eye on helping radiologists to become more efficient, collaborate, and avoid burnout, Philips focused on its new artificial intelligence (AI) and imaging informatics offerings at RSNA 2022. Read More
Video from RSNA 2022: Gadopiclenol emerges as gadolinium-based contrast agent
December 1, 2022 -- CHICAGO - Gadopiclenol is emerging as an alternative gadolinium-based MRI contrast agent. To learn more about its potential, we spoke with Prof. Dr. Christiane Kuhl from the University Hospital Aachen in Germany at RSNA 2022. Read More
French group flies the flag for Europe in RSNA poster hall
December 1, 2022 -- Members of a research group in Nantes -- known as the jewel of the Loire Valley in northwest France -- received Europe's only magna cum laude award when the prestigious prizes were handed out on day 4 of the RSNA meeting. Read More
Pylarify PET/MRI shows value in selecting patients for focal ablative therapy
November 30, 2022 -- CHICAGO - F-18 DCFPyL (Pylarify) PET/MRI appears useful when determining whether men with low-risk prostate cancer are candidates for focal ablative therapy, according to research presented at RSNA 2022. Read More
PSMA-PET improves prostate cancer management in most patients
November 30, 2022 -- CHICAGO - Gallium-68 prostate-specific membrane antigen (PSMA) imaging detected more lesions in prostate cancer patients than previous approaches and changed management decisions in a majority of patients, according to research presented at RSNA 2022. Read More
GE leans into improving patient outcomes, healthcare efficiency
November 29, 2022 -- CHICAGO - At this year's RSNA meeting, GE Healthcare is focusing on two goals: improving patient outcomes and boosting the efficiency of the healthcare enterprise. Promotion of these themes comes just weeks before GE is set to spin off its healthcare division into a standalone firm to be called GE HealthCare, which it plans to do in January. Read More
FCH-PET shows value detecting tumors in primary hyperparathyroidism
November 29, 2022 -- CHICAGO - An experimental PET imaging approach using a radiotracer called F-18 fluorocholine appears effective in detecting tumors in patients with primary hyperparathyroidism, according to research presented November 29 at the RSNA annual meeting. Read More
AI increases PET/CT reporting efficiency in lymphoma staging
November 28, 2022 -- CHICAGO - An artificial intelligence (AI)-assisted software tool can decrease PET/CT reporting time in lymphoma staging without adversely affecting report quality, according to research presented November 28 at RSNA 2022. Read More
What's the most cost-effective way to diagnose liver metastases?
November 27, 2022 -- CHICAGO - MRI appears to be the most cost-effective modality for diagnosing colorectal cancer liver metastases, a presenter said in a November 27 session at RSNA 2022. Read More
NaF-PET shows bone formation in psoriatic arthritis patients
November 18, 2022 -- F-18 sodium fluoride (NaF) PET/CT may be a valuable tool for imaging patients with psoriatic arthritis, as it reveals new bone formation in peripheral joints missed on clinical evaluation, according to a Dutch group. Read More